Pharmaceutical

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Colorectal Cancer.

Jan 3, 2024 - 18:00
PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval
PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Colorectal Cancer.
Read the original article

Tags:

Previous Article

MediLink and Roche partner on cancer drug development

Next Article

Roche buys Point-of-Care Technology Platform from LumiraDx

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

After Gaza tweet, firing of life sciences journal editor sparks freedom of speech concerns

After Gaza tweet, firing of life sciences journal edito...

Oct 26, 2023

STAT+: Not-for-profit CommonSpirit Health paid its CEO $35 million in 2021

STAT+: Not-for-profit CommonSpirit Health paid its CEO ...

Aug 15, 2023

ProMED, an early warning system on disease outbreaks, appears near collapse

ProMED, an early warning system on disease outbreaks, a...

Aug 3, 2023